FATE
Fate Therapeutics IncCompany with tickers: FATE
CIK
1434316
CUSIP
31189P102
Shares Outstanding
116,559,186
13F Activity (30d)
146 filings
135 filers
Price
$2.20
Market Cap
$279.16M
P/E Ratio
-1.91
EPS (Diluted)
$-1.15
52W High
$2.47
52W Low
$0.91
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $1,299,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $34,299,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Research & Development | $24,703,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Operating Income | $-33,000,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Net Income | $-31,213,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| EPS (Basic) | $-0.26 | USD/shares | 2026-03-31 | 10-Q | 2026-05-13 |
| EPS (Diluted) | $-0.26 | USD/shares | 2026-03-31 | 10-Q | 2026-05-13 |